EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Rights to antibody drug by China's Keymed change hands in Gilead acquisition of Ouro | South China Morning Post
Gilead Sciences Acquires Ouro Medicines for Over $2 Billion to Expand Immunology Pipeline, ETPharma
Dow Jones Top Company Headlines at 9 PM ET: Estee Lauder in Talks to Acquire Spain's Puig to Create Global Beauty Giant | Gilead ... | Morningstar
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets - Update | Morningstar
Gilead to buy Ouro Medicines for up to $2.2 billion
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion | Morningstar
Gilead to buy biotech firm Ouro Medicines in over $2 billion deal
Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
Galapagos en Gilead in vergevorderde gesprekken over samenwerking om een first-in-class T-cel-engagerprogramma voor auto-immuunziekten verder te ontwikkelen
-- Acquisition Adds Clinical Stage Bispecific BCMAxCD3 T Cel
Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases
Demand surges in Nigeria for new HIV prevention injection ahead of rollout | Africanews
Wealth Enhancement Advisory Services LLC Has $77.22 Million Stock Holdings in Gilead Sciences, Inc. $GILD
Nordea Investment Management AB Has $630.06 Million Stake in Gilead Sciences, Inc. $GILD
Henrickson Nauta Wealth Advisors Inc. Purchases 7,074 Shares of Gilead Sciences, Inc. $GILD - Markets Daily
Nordea Investment Management AB Increases Position in Gilead Sciences, Inc. $GILD - Stock Observer
IAM Advisory LLC Takes $1.27 Million Position in Gilead Sciences, Inc. $GILD
BCGM Wealth Management LLC Makes New Investment in Gilead Sciences, Inc. $GILD
Union Bancaire Privee UBP SA Grows Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Therapeutics Stocks Q4 Teardown: Moderna (NASDAQ:MRNA) Vs The Rest
Groupama Asset Managment Grows Stock Holdings in Gilead Sciences, Inc. $GILD
Anderson Hoagland & Co. Purchases New Stake in Gilead Sciences, Inc. $GILD
AIA Group Ltd Increases Stock Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by Wilmington Savings Fund Society FSB - Daily Political
GILD: HIV Franchise And Oncology Expansion Will Shape Bullish Long Term Outlook
Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care
Gilead Sciences, Inc. $GILD Shares Bought by Swiss Life Asset Management Ltd
Johanna Mercier Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - Markets Daily
Swiss Life Asset Management Ltd Purchases 31,807 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Sunbelt Securities Inc. Trims Holdings in Gilead Sciences, Inc. $GILD - Daily Political
A Look At Gilead Sciences (GILD) Valuation As Recent Returns Send Mixed Signals
Danske Bank A S Takes $133.05 Million Position in Gilead Sciences, Inc. $GILD
Captrust Financial Advisors Has $211.80 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead Sciences, Inc. $GILD Shares Purchased by Achmea Investment Management B.V.
Gilead Sciences, Inc. $GILD Holdings Cut by WBI Investments LLC - Daily Political
Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares
Gilead Sciences (NASDAQ:GILD) CFO Sells $432,690.00 in Stock
Fort Point Capital Partners LLC Sells 8,153 Shares of Gilead Sciences, Inc. $GILD
CSM Advisors LLC Sells 42,400 Shares of Gilead Sciences, Inc. $GILD
Bank of Nova Scotia Sells 319,843 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences Conference: 6-Month HIV Regimens, 12-Month PrEP, Livdelzi Expansion, Oncology Push - Stock Observer
Gilead Sciences at Barclays: CFO touts YEZTUGO launch, Arcellx deal and "long cycle" growth - Daily Political
2 Mega-Cap Nasdaq Stocks with Unusual Options Activity: What to Watch
Gilead Sciences, Inc. (NASDAQ:GILD) Short Interest Down 15.7% in February
Gilead Sciences, Inc. $GILD Shares Sold by Holocene Advisors LP - Daily Political
Crawford Investment Counsel Inc. Decreases Stock Position in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades
Calydon Capital Has $7.34 Million Position in Gilead Sciences, Inc. $GILD
BNP Paribas Has $7.71 Million Stake in Gilead Sciences, Inc. $GILD
Banco Bilbao Vizcaya Argentaria S.A. Grows Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Rating of "Moderate Buy" from Brokerages - Markets Daily
Ameriprise Financial Inc. Buys 400,002 Shares of Gilead Sciences, Inc. $GILD
Alliancebernstein L.P. Sells 258,213 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences (NASDAQ:GILD) Upgraded by Wall Street Zen to Strong-Buy Rating
BNP Paribas Sells 16,020 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Goldman Sachs Healthcare Stocks: Top 10 Stock Picks
Top Pharmaceutical Stocks To Watch Today - March 14th - Stock Observer
Dodge & Cox Trims Stock Position in Gilead Sciences, Inc. $GILD
Gilead Sciences (NASDAQ:GILD) Upgraded at Wall Street Zen
Harvest Fund Management Co. Ltd Has $10.34 Million Position in Gilead Sciences, Inc. $GILD - Stock Observer
Gilead Sciences, Inc. $GILD Shares Sold by Prudential PLC - Daily Political
Dodge & Cox Reduces Stock Position in Gilead Sciences, Inc. $GILD - Daily Political
EHP Funds Inc. Makes New Investment in Gilead Sciences, Inc. $GILD - Daily Political
Analysts Set Expectations for Gilead Sciences Q1 Earnings - Markets Daily
Martingale Asset Management L P Decreases Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Invesco Ltd. Purchases 1,618,453 Shares of Gilead Sciences, Inc. $GILD
Johnson Financial Group Inc. Lowers Stake in Gilead Sciences, Inc. $GILD - Daily Political
How Renewed Wall Street Optimism Around HIV, Oncology And IP Runway At Gilead Sciences (GILD) Has Changed Its Investment Story
Gilead Sciences Sees Unusually Large Options Volume (NASDAQ:GILD) - Daily Political
Investors Buy Large Volume of Gilead Sciences Call Options (NASDAQ:GILD) - Zolmax
Stock Traders Purchase Large Volume of Call Options on Gilead Sciences (NASDAQ:GILD)
Promising Pharmaceutical Stocks To Watch Now - March 12th - Stock Observer
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum And Mixed Fair Value Signals
Inceptionr LLC Takes Position in Gilead Sciences, Inc. $GILD - Markets Daily
Bokf Na Increases Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Bokf Na Raises Stock Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Stake Boosted by SageView Advisory Group LLC - Daily Political
Franklin Resources Inc. Decreases Stake in Gilead Sciences, Inc. $GILD - Daily Political
3 Top-Rated Stocks to Buy to Hedge Against Stagflation as Middle East Conflict Drags On
Mackenzie Financial Corp Lowers Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Magnetar Financial LLC Increases Stock Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by Mackenzie Financial Corp - Stock Observer
Gilead Sciences, Inc. (GILD) to Issue Quarterly Dividend of $0.82 on March 30th - Stock Observer
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
Jefferies Financial Group Begins Coverage on Gilead Sciences (NASDAQ:GILD) - Markets Daily
Capital International Inc. CA Raises Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead news
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
